// insider-profile

Mikhak Zamaneh

OfficerTitleChief Medical OfficerView on SEC.gov ↗

This page tracks every SEC Form 4 filing by Mikhak Zamaneh, Chief Medical Officer: 5 transactions in total, including 1 open-market purchase and 0 sales. Each record is parsed directly from the original filing, with amendments reconciled so a corrected filing never double-counts.

// activity-summary

No insider transactions in the last 30 days.

// track-record

$30K
Total purchased
$0
Total sold
1
1B · 0S transactions
Net buyer
Overall direction

Most active in

Largest trade: $30K in TFFP (Aug 2023)Filing history: Aug 2023Jul 2024Based on last 5 filings

Transaction History

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jul 3, 2024Mikhak ZamanehTFFP
Award
10,184$0.00$0K
Jul 3, 2024Mikhak ZamanehTFFP
Award
10,184$0.00$0K
Apr 18, 2024Mikhak ZamanehTFFP
Award
5,300$0.00$0K
Apr 18, 2024Mikhak ZamanehTFFP
Award
10,600$0.00$0K
Aug 15, 2023Mikhak ZamanehTFFP
Purchase
120,000$0.25$30K

// how to read this

Reading an insider's Form 4 history

Corporate insiders — directors, officers, and holders of more than 10% of a company's stock — must report their trades to the SEC on Form 4 within two business days. Looking at one insider's filings over time shows whether they tend to buy on the open market (a discretionary use of their own money, generally the strongest signal), sell, or simply receive and exercise equity awards as compensation.

The track record above measures how this insider's past open-market purchases performed in the months after each filing. Trades made under a pre-scheduled Rule 10b5-1 plan are flagged because they carry no timing signal. To pull any insider's full history programmatically, see the insider trading API or our guide to reading Form 4 filings.